From Evidence to Practice in Low-Risk Thyroid Cancer

• by Lia D. Delaney, Carolyn D. Seib

• October 30, 2026

Ashley Marton, M.D.C.M., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Hematologist and Medical Oncologist

Hematologist and medical oncologist Ashley Marton, M.D.C.M., has joined the Eugene M. and Christine E. Lynn Cancer Institute - Boynton Beach, part of Baptist Health Cancer Care

• by

• October 22, 2026

• 2 min

Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

• by Stephan P. Tenbaum, Paloma Ordóñez-Morán, Isabel Puig, Irene Chicote, Oriol Arqués, Stefania Landolfi, Yolanda Fernández, José Raúl Herance, Juan D. Gispert, Leire Mendizabal, Susana Aguilar, Santiago Ramón y. Cajal, Simó Schwartz, Ana Vivancos, Eloy Espín, Santiago Rojas, José Baselga, Josep Tabernero, Alberto Muñoz, Héctor G. Palmer

• October 22, 2026

Author Correction: Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis

• by Edward D. Esplin, Casey Hanson, Si Wu, Aaron M. Horning, Nasim Bararpour, Stephanie A. Nevins, Lihua Jiang, Kévin Contrepois, Hayan Lee, Tuhin K. Guha, Zheng Hu, Rozelle Laquindanum, Meredith A. Mills, Hassan Chaib, Roxanne Chiu, Ruiqi Jian, Joanne Chan, Mathew Ellenberger, Winston R. Becker, Bahareh Bahmani, Aziz Khan, Basil Michael, Annika K. Weimer, D. Glen Esplin, Jeanne Shen, Samuel Lancaster, Emma Monte, Thomas V. Karathanos, Uri Ladabaum, Teri A. Longacre, Anshul Kundaje, Christina Curtis, William J. Greenleaf, James M. Ford, Michael P. Snyder

• October 22, 2026